I now have all the content needed. Let me compile the complete Chapter 17.Here is the complete Chapter 17: Local and Humoral Control of Tissue Blood Flow from Guyton and Hall Textbook of Medical Physiology, with all content, tables, and figures included.
Chapter 17: Local and Humoral Control of Tissue Blood Flow
Guyton and Hall Textbook of Medical Physiology
LOCAL BLOOD FLOW IS CONTROLLED IN RESPONSE TO TISSUE NEEDS
A fundamental principle of circulatory function is that most tissues have the ability to control their own local blood flow in proportion to their specific metabolic needs. Some of the specific needs of the tissues for blood flow include the following:
- Delivery of oxygen to the tissues
- Delivery of other nutrients such as glucose, amino acids, and fatty acids
- Removal of carbon dioxide from the tissues
- Removal of hydrogen ions from the tissues
- Maintenance of proper concentrations of ions in the tissues
- Transport of various hormones and other substances to the different tissues
Certain organs have special requirements. For example, blood flow to the skin determines heat loss from the body and, in this way, helps control body temperature. Also, delivery of adequate quantities of blood plasma to the kidneys allows the kidneys to filter and excrete the waste products of the body and to regulate body fluid volumes and electrolytes.
Variations in Blood Flow in Different Tissues and Organs
Note the very large blood flows listed in Table 17.1 for some organs - for example, several hundred milliliters per minute per 100 grams of thyroid or adrenal gland tissue and a total blood flow of 1350 mL/min in the liver, which is 95 mL/min/100 g of liver tissue.
Also note the extremely large blood flow through the kidneys - 1100 mL/min. This large amount of flow, about 22% of the cardiac output, is required for the kidneys to perform their function of cleansing the blood of waste products and regulating composition of the body fluids precisely.
Conversely, all the inactive skeletal muscles of the body together have a blood flow of only about 750 mL/min even though the muscles constitute 30% to 40% of the total body mass. In the resting state, the metabolic activity of the muscles is low, as is the blood flow - only 4 mL/min/100 g. Yet, during heavy exercise, muscle metabolic activity can increase more than 60-fold and the blood flow as much as 20-fold, increasing to as high as 16,000 mL/min in the body's total muscle vascular bed (or 80 mL/min/100 g of muscle).
Table 17.1 - Blood Flow to Different Organs and Tissues Under Basal Conditions
| Organ | Blood Flow (mL/min) | % of Cardiac Output | mL/min/100g |
|---|
| Brain | 700 | 14% | 50 |
| Heart | 225 | 4-5% | 70 |
| Bronchi | 100 | 2% | - |
| Kidneys | 1100 | 22% | 360 |
| Liver | 1350 | 27% | 95 |
| - Portal (75%) | 1050 | - | - |
| - Arterial (25%) | 300 | - | - |
| Muscle (inactive) | 750 | 15% | 4 |
| Bone | 250 | 5% | 3 |
| Skin (cool weather) | 460 | 9% | 13 |
| Thyroid gland | 50 | 1% | 400 |
| Adrenal glands | 25 | 0.5% | 300 |
| Other tissues | 175 | 3.5% | 1.3 |
| Total | 5000 | 100% | - |
Importance of Blood Flow Control By the Local Tissues
Experiments have shown that the blood flow to each tissue usually is normally regulated at the minimal level that will supply the tissue's requirements - no more, no less. For example, in tissues for which the most important requirement is delivery of oxygen, the blood flow is controlled at a level only slightly more than that required to maintain full tissue oxygenation but no more than this. By controlling local blood flow in such an exact way, the tissues rarely experience oxygen nutritional deficiency, and the workload on the heart is kept at a minimum.
MECHANISMS OF LOCAL BLOOD FLOW CONTROL
Local blood flow control can be divided into two phases: acute control and long-term control.
- Acute control is achieved by rapid changes (within seconds to minutes) in local vasodilation or vasoconstriction of the arterioles, metarterioles, and precapillary sphincters that maintain appropriate local tissue blood flow.
- Long-term control means slow, controlled changes in flow over a period of days, weeks, or even months. In general, these long-term changes provide even better control of the flow in proportion to the needs of the tissues. These changes result from increases or decreases in the physical sizes and numbers of blood vessels supplying the tissues.
ACUTE CONTROL OF LOCAL BLOOD FLOW
Increases in Tissue Metabolism Increase Tissue Blood Flow
Fig. 17.1 shows the approximate acute effect on blood flow of increasing the rate of metabolism in a tissue such as in a skeletal muscle. Note that an increase in metabolism up to about eight times normal increases blood flow acutely about fourfold to sixfold.
Figure 17.1 (schematic):
6 | /---\
| / \
4 | / \ Blood flow
| / \
2 |__________________/ \___
|
0 |_____________________________________
0 2 4 6 8 10
Tissue metabolism (× normal)
Effect of increasing tissue metabolic rate on tissue blood flow.
Possible Causes of Acute Local Blood Flow Regulation - The Vasodilator Theory
The vasodilator theory is probably the most widely accepted theory for explaining acute local blood flow regulation. It suggests that the greater the rate of metabolism or the less the availability of oxygen or other nutrients to a tissue, the greater the rate of formation of vasodilator substances in the tissue cells.
These vasodilator substances are believed to diffuse through the tissues to the precapillary sphincters, metarterioles, and arterioles to cause dilation. The greater the rate of metabolism or the less the availability of oxygen, the greater the vasodilation, and the greater the blood flow.
Among the most important vasodilator substances are:
- Adenosine - probably the most important vasodilator in heart muscle; released from cardiac muscle cells when oxygen delivery is insufficient
- Carbon dioxide
- Adenosine phosphate compounds (AMP, ADP, ATP)
- Histamine
- Potassium ions
- Hydrogen ions (lactic acid)
Many of these substances are released from the cells in direct proportion to their rate of oxygen consumption. As more oxygen is consumed by increased metabolism, more vasodilator substances accumulate locally, causing local vasodilation and increased blood flow.
The Oxygen Demand Theory (Nutrient Demand Theory)
Some physiologists believe that oxygen itself (or other nutrients) is the primary regulator of local blood flow. They propose that the precapillary sphincters and metarterioles close when oxygen concentration is too high and open when oxygen concentration is too low. The proposed mechanism is:
- When tissue oxygen falls (due to high metabolic rate), smooth muscle of vessels cannot maintain tone (requires oxygen to contract), so vessels dilate
- When oxygen rises, smooth muscle contracts and vessels constrict
This explains regulation without invoking a specific vasodilator substance. Both vasodilator and oxygen demand theories likely operate simultaneously.
Special Examples of Acute Metabolic Control of Local Blood Flow
The mechanisms described thus far for local blood flow control are called metabolic mechanisms because they all function in response to the metabolic needs of the tissues. Two additional special examples of metabolic control of local blood flow are:
- Reactive hyperemia
- Active hyperemia (shown in Fig. 17.4)
Reactive Hyperemia Occurs After Tissue Blood Flow Is Blocked for a Short Time
When the blood supply to a tissue is blocked for a few seconds to as long as 1 hour or more and then is unblocked, blood flow through the tissue usually increases immediately to four to seven times normal. This increased flow will continue for a few seconds if the block has lasted only a few seconds but sometimes continues for as long as many hours if the blood flow has been stopped for an hour or more. This phenomenon is called reactive hyperemia.
Reactive hyperemia is another manifestation of the local metabolic blood flow regulation mechanism - that is, lack of flow sets into motion all the metabolic factors that cause vasodilation. After short periods of vascular occlusion, the extra blood flow during the reactive hyperemia phase lasts long enough to repay almost exactly the tissue oxygen deficit that has accrued during the period of occlusion. This mechanism emphasizes the close connection between local blood flow regulation and delivery of oxygen and other nutrients to the tissues.
Active Hyperemia Occurs When Tissue Metabolic Rate Increases
When a tissue becomes highly active, such as an exercising muscle, the gut during digestion of food, a gastrointestinal gland during a hypersecretory period, or even the brain during increased mental activity, the rate of blood flow through the tissue increases (see Fig. 17.4). The increase in local metabolism causes the cells to devour tissue fluid nutrients rapidly and release increased quantities of vasodilator substances. The result is dilation of local blood vessels and increased local blood flow.
In this way, the active tissue receives the additional nutrients required to sustain its increased level of activity. As noted earlier, active hyperemia in skeletal muscle can increase local muscle blood flow as much as 20-fold during intense exercise.
Figure 17.4 - Upper graph: Reactive hyperemia in a tissue after temporary occlusion of the artery supplying blood flow - flow rises to 5-6x normal immediately after release. Lower graph: Active hyperemia following increased tissue metabolic activity (muscle stimulation) - flow rises to 7x normal during stimulation.
Autoregulation of Blood Flow During Changes in Arterial Pressure - Metabolic and Myogenic Mechanisms
In any tissue of the body, a rapid increase in arterial pressure causes an immediate rise in blood flow. However, within less than 1 minute, blood flow in most tissues returns almost to the normal level even though the arterial pressure is kept elevated. This return of flow toward normal is called autoregulation.
After autoregulation has occurred, blood flow in most tissues will be related to arterial pressure approximately in accord with the solid acute curve in Fig. 17.5. Note that between arterial pressures of about 70 and 175 mm Hg, blood flow increases only 20% to 30%, even though arterial pressure increases 150%. In some tissues, such as the brain, kidneys, and heart, this autoregulation is even more precise.
Figure 17.5 (schematic):
Blood
flow
(× normal)
2.0 | Acute curve
| /
1.5 | /---/
| / (long-term curve: nearly flat)
1.0 |--/----------------------------------
|
0.5 |
|
0 |________________________________
0 50 100 150 200 250
Arterial pressure (mm Hg)
The solid curve shows acute autoregulation (20-30% rise over 70-175 mmHg range). The dashed green curve shows long-term regulation (almost perfectly flat - blood flow nearly constant despite wide BP changes).
Metabolic Mechanism
When arterial pressure increases, blood flow increases momentarily. But the excess flow delivers extra oxygen and nutrients to the tissue and washes out vasodilator substances. The resulting decrease in vasodilator concentration (and increased oxygen tension) causes vasoconstriction of the arterioles and precapillary sphincters, returning blood flow toward normal. Conversely, when arterial pressure falls, vasoconstriction initially reduces flow, but nutrient depletion and vasodilator accumulation then cause vasodilation to restore flow.
Myogenic Mechanism
The myogenic mechanism suggests that blood vessels react directly to increased intravascular pressure by contracting. Smooth muscle cells in the arteriolar walls have an intrinsic property: when stretched by an increase in blood pressure, they contract. This reduces vessel diameter and thus restores blood flow toward normal. Conversely, a decrease in arterial pressure reduces wall stretch, causing the vessel to relax and dilate, thus restoring flow upward. Evidence for the myogenic mechanism includes:
- Isolated small blood vessels exposed to sudden increases in intravascular pressure constrict within seconds
- This intrinsic contraction is independent of nervous innervation or humoral factors
- It is most prominent in arterioles and small arteries
The myogenic mechanism is probably more important for instantaneous control of blood flow and for preventing rupture of small blood vessels.
Special Mechanisms for Acute Blood Flow Control in Specific Tissues
The microcirculation of several tissues is controlled by special mechanisms distinct from the general metabolic mechanisms:
- Kidney: Tubuloglomerular feedback - macula densa cells respond to sodium delivery to adjust afferent arteriolar tone
- Brain: CO₂ and H⁺ concentrations are the dominant local regulators of cerebral blood flow
- Skin: Blood flow is primarily regulated by skin temperature and the sympathetic nervous system (for thermoregulation), not primarily by metabolic needs
- Coronary circulation: Adenosine released from myocardial cells is the predominant local vasodilator; blood flow is tightly coupled to myocardial oxygen demand
Control of Tissue Blood Flow: Endothelium-Derived Relaxing and Constricting Factors
Nitric Oxide Is a Vasodilator Released From Healthy Vascular Endothelium
Perhaps the most important endothelium-derived vasodilating factor is nitric oxide (NO) (sometimes called endothelium-derived relaxing factor, or EDRF). It is released continually from vascular endothelial cells in healthy blood vessels, and it:
- Prevents excessive vasoconstriction
- Inhibits platelet aggregation (thus preventing blood clots)
- Inhibits adhesion of white blood cells to the endothelium
- Helps prevent abnormal proliferation of vascular smooth muscle cells
NO is synthesized from L-arginine in endothelial cells by the enzyme nitric oxide synthase (NOS). It diffuses to the underlying smooth muscle, where it activates guanylyl cyclase, increasing cyclic GMP (cGMP), which leads to smooth muscle relaxation and vasodilation.
Stimuli for NO release:
- Shear stress on the endothelium (mechanical deformation by blood flow)
- Acetylcholine
- Bradykinin
- Histamine
This explains the flow-dependent vasodilation phenomenon: when blood flow in an artery increases (e.g., during exercise), the resulting increase in shear stress on the endothelium stimulates NO release, causing the artery to dilate and accommodate the increased flow.
Clinical importance: Atherosclerosis and other endothelial diseases reduce NO synthesis and release, impairing flow-dependent vasodilation and predisposing to hypertension and coronary spasm.
Clinical Application of Drugs That Increase Vascular NO
Several important drugs act by enhancing NO effects:
- Nitroglycerin and nitrate drugs - metabolized to NO in vascular smooth muscle; used for angina pectoris
- Sildenafil (Viagra) and other PDE-5 inhibitors - block the enzyme (cGMP-specific phosphodiesterase-5) that degrades cGMP, thereby prolonging the effects of NO. Major clinical use: treating erectile dysfunction. Penile erection is caused by parasympathetic nerve impulses through the pelvic nerves to the penis, where the neurotransmitters acetylcholine and NO are released. By preventing the degradation of NO, the PDE-5 inhibitors enhance the dilation of the blood vessels in the penis and aid in erection.
Endothelin is a Powerful Vasoconstrictor Released By Damaged Endothelium
Endothelial cells also release vasoconstrictor substances. One of the most important of these is endothelin, a large, 21-amino acid peptide that requires only minute amounts (nanograms) to cause powerful vasoconstriction. This substance is present in endothelial cells of most blood vessels but greatly increases when the vessels are injured.
The usual stimulus for release is damage to the endothelium, such as that caused by crushing of the tissues or a traumatizing chemical in the blood vessel. After severe blood vessel damage, local release of endothelin and subsequent vasoconstriction helps prevent extensive bleeding from arteries as large as 5 millimeters in diameter that might have been torn open by crushing injury.
Increased endothelin release may also contribute to vasoconstriction when the endothelium is damaged by hypertension. Drugs that block endothelin receptors have been used to treat pulmonary hypertension but generally have not been used for lowering blood pressure in patients with systemic arterial hypertension.
LONG-TERM BLOOD FLOW REGULATION
Thus far, most of the mechanisms for local blood flow regulation discussed act within a few seconds to a few minutes after local tissue conditions have changed. Yet, even after full activation of these acute mechanisms, the blood flow usually is adjusted only about three-quarters of the way to the exact requirements of the tissues.
For example, when the arterial pressure suddenly increases from 100 to 150 mm Hg, the blood flow increases almost instantaneously, by about 100%. Then, within 30 seconds to 2 minutes, the flow in many tissues decreases back to about 10% to 15% above the original control value.
Although this example illustrates the rapidity of the acute mechanisms for local blood flow regulation, it also demonstrates that the regulation is still incomplete because a 10% to 15% excess blood flow remains in some tissues.
However, over a period of hours, days, and weeks, long-term blood flow regulation develops, in addition to the acute control, providing more precise regulation. In the aforementioned example, if arterial pressure remains at 150 mm Hg indefinitely, blood flow through the tissues gradually approaches almost exactly the normal flow level within a few weeks. Fig. 17.5 shows (dashed green curve) the extreme effectiveness of this long-term local blood flow regulation. Once the long-term regulation has had time to occur, long-term changes in arterial pressure between 50 and 200 mm Hg have little effect on the rate of tissue blood flow.
Long-term regulation of blood flow is especially important when the metabolic demands of a tissue change. Thus, if a tissue becomes chronically overactive and requires increased quantities of oxygen and other nutrients, the arterioles and capillary vessels usually increase both in number and size within a few weeks to match the needs of the tissue, unless the circulatory system has become pathological or too old to respond.
Blood Flow Regulation By Changes in Tissue Vascularity
A key mechanism for long-term local blood flow regulation is to change vascularity of the tissues. For example, if metabolism in a tissue is increased for a prolonged period, vascularity increases, a process generally called angiogenesis; if metabolism is decreased, vascularity decreases.
Fig. 17.7 shows the large increase in the number of capillaries in a tissue in which oxygen consumption has been increased chronically, as occurs in exercising muscles over time.
Figure 17.7 (schematic):
Normal muscle: Trained/active muscle:
[ === ] [ === === === ]
[ === ] [ === === === ]
[ === ] [ === === === ]
Fewer, widely Many more capillaries,
spaced capillaries closer together
Angiogenesis in exercised muscle tissue: capillary density increases greatly with chronic increased metabolic activity.
Role of Oxygen in Long-Term Regulation
Oxygen plays an especially important role in the long-term regulation of vascularity. Specifically, if the metabolic rate of a tissue increases, the oxygen consumption also increases. This leads to decreased tissue oxygen concentration. The low oxygen:
- Stimulates growth of new blood vessels (angiogenesis) from existing capillaries
- Vasodilation of existing vessels
- Increased opening of previously closed capillaries
Role of VEGF in Angiogenesis
Vascular endothelial growth factor (VEGF) is the principal angiogenic growth factor. It is:
- Produced by cells experiencing hypoxia (low oxygen)
- Stimulates endothelial cell proliferation and migration
- Promotes formation of new capillary sprouts
- Regulated by hypoxia-inducible factor (HIF-1α)
Other angiogenic factors include:
- Fibroblast growth factor (FGF)
- Platelet-derived growth factor (PDGF)
- Angiopoietins
Clinical relevance: These pathways are exploited by tumors (malignant angiogenesis). Anti-VEGF drugs (e.g., bevacizumab) are used in cancer treatment to starve tumors of their blood supply.
Blood Flow Regulation By Development of Collateral Circulation
When a major artery or vein is blocked, alternative vascular pathways often develop or enlarge to restore blood flow to the affected tissue. This is called collateral circulation development. Key points:
- Begins within seconds to minutes (pre-existing collateral vessels open)
- Enlargement of collaterals occurs over days to weeks
- Chronic low blood flow stimulates VEGF and other growth factors that drive vessel growth
- Example: gradual coronary artery occlusion often leads to extensive collateral coronary vessels, reducing the risk of infarction compared to acute total occlusion
Vascular Remodeling in Response to Chronic Changes in Blood Flow or Pressure
Vascular remodeling refers to structural changes in blood vessel walls in response to chronic hemodynamic changes.
Response to Chronic Increased Blood Flow
When blood flow chronically increases (e.g., after creation of an arteriovenous fistula):
- The luminal diameter of the affected artery increases (outward remodeling) due to increased shear stress on the vessel wall
- Wall thickness may remain unchanged - resulting in increased cross-sectional area of the vascular wall
Example: In patients with renal failure who undergo dialysis, an arterial-venous (A-V) fistula is created directly from the radial artery to the antecubital vein of the forearm to permit vascular access for dialysis. Blood flow rate in the radial artery may increase as much as 10 to 50 times the normal flow rate, depending on the patency of the fistula.
- On the arterial side: high flow and shear stress → outward remodeling (luminal enlargement)
- On the venous side: increased pressure AND blood flow → outward hypertrophic remodeling (increased lumen diameter, increased wall thickness, increased cross-sectional area)
This pattern is consistent with the concept that:
- Long-term increases in vascular wall tension cause hypertrophy and increased wall thickness in large blood vessels
- Increased blood flow rate and shear stress cause outward remodeling and increased luminal diameter
Response to Chronic Reduced Blood Flow or Pressure
- Reduced blood pressure → vessel wall thickness usually decreases
- Reduced blood flow → luminal diameter decreases
Thus, vascular remodeling is an important adaptive response of the blood vessels to tissue growth and development, as well as to physiological and pathological changes in blood pressure and blood flow to the tissues.
HUMORAL CONTROL OF THE CIRCULATION
Substances secreted or absorbed into the body fluids - such as hormones and locally produced factors - also contribute to blood flow regulation. Some of these substances are formed by special glands and transported in the blood throughout the entire body. Others are formed in local tissue areas and cause only local circulatory effects.
Figure 17.8 (schematic - humoral factors summary):
┌─────────────────────────────────────────────────────┐
│ HUMORAL CONTROL OF CIRCULATION │
├───────────────────┬─────────────────────────────────┤
│ VASOCONSTRICTORS│ VASODILATORS │
├───────────────────┼─────────────────────────────────┤
│ Norepinephrine │ Bradykinin │
│ Epinephrine* │ Histamine │
│ Angiotensin II │ Prostaglandins (some) │
│ Vasopressin (ADH) │ Serotonin* │
│ Endothelin │ Epinephrine* (some tissues) │
│ Serotonin* │ Nitric oxide │
└───────────────────┴─────────────────────────────────┘
(* = effect is tissue-dependent)
VASOCONSTRICTORS
Norepinephrine and Epinephrine
Norepinephrine is an especially powerful vasoconstrictor hormone; epinephrine is less powerful as a vasoconstrictor and, in some tissues, even causes mild vasodilation. A special example of vasodilation caused by epinephrine is that which occurs to dilate the coronary arteries during increased heart activity.
When the sympathetic nervous system is stimulated in most parts of the body during stress or exercise, the sympathetic nerve endings in the individual tissues release norepinephrine, which:
- Excites the heart
- Constricts the veins and arterioles
In addition, the sympathetic nerves to the adrenal medulla cause these glands to secrete norepinephrine and epinephrine into the blood. These hormones then circulate to all areas of the body and cause almost the same effects on the circulation as direct sympathetic stimulation, thus providing a dual system of control:
- Direct nerve stimulation
- Indirect effects of norepinephrine and/or epinephrine in the circulating blood
Angiotensin II
Angiotensin II is another powerful vasoconstrictor. As little as one-millionth of a gram can increase the arterial pressure of a person by 50 mm Hg or more.
Angiotensin II powerfully constricts the small arterioles, and if this constriction occurs in an isolated tissue area, blood flow to that area can be severely depressed, at least transiently. When plasma levels of angiotensin II or other vasoconstrictors are chronically elevated, increases in blood pressure and local control mechanisms often restore blood flow to nearly normal levels.
The real importance of angiotensin II as a vasoconstrictor is that it provides a hormonal mechanism for the kidneys to control arterial pressure: when the kidneys produce large quantities of renin in response to reduced arterial pressure, the renin → angiotensin I → angiotensin II pathway raises arterial pressure back toward normal. This renin-angiotensin system is discussed in detail in chapters dealing with the kidney and arterial pressure regulation.
Vasopressin (ADH - Antidiuretic Hormone)
Vasopressin is perhaps one of the most powerful vasoconstrictors in the body. It is formed in the hypothalamus and stored in the posterior pituitary gland. It is released in response to:
- Decreased blood volume
- Increased plasma osmolality
Primary role: Regulation of water reabsorption by the collecting ducts of the kidneys. However, it also causes significant vasoconstriction in blood vessels throughout the body, especially in response to severe hypovolemia or hemorrhage. During hemorrhage, vasopressin (along with angiotensin II and norepinephrine) is released to help maintain arterial pressure.
VASODILATORS
Bradykinin
Bradykinin is a small polypeptide (9 amino acids) that can cause marked vasodilation. It is formed from a protein precursor called kallidin (or kininogen) in the blood and tissue fluids by the enzyme kallikrein.
- Bradykinin causes powerful arteriolar dilation and increased capillary permeability
- It plays a role in inflammation and allergic reactions
- It stimulates release of NO from endothelium (contributing to vasodilation)
- Its plasma half-life is very short (~15 seconds), as it is rapidly inactivated by the enzyme kininase (also known as angiotensin-converting enzyme, ACE)
Clinical note: ACE inhibitors (used to treat hypertension) prevent bradykinin degradation, which contributes to the cough side effect of ACE inhibitors (bradykinin accumulates in airways and causes cough).
Histamine
Histamine is released in essentially every tissue of the body when the tissue becomes damaged or inflamed or when an allergic reaction occurs. Most of the histamine is released from mast cells and basophils.
Effects on circulation:
- Causes arteriolar dilation
- Increases capillary permeability (allowing plasma proteins and fluid to leak into the tissues - contributing to edema)
- Plays an important role in local blood flow increase during injury and allergic reactions
Prostaglandins
Prostaglandins are a family of lipid substances derived from arachidonic acid that are present in significant quantities in almost every tissue of the body. Some prostaglandins are vasodilators; others are vasoconstrictors. However, many of the prostaglandins found in the blood are believed to be the result of local tissue formation and are rapidly inactivated as they pass through the lungs. Therefore, their significance in overall systemic control of blood flow remains uncertain. However, locally formed prostaglandins are important in regulating blood flow in various tissues.
VASCULAR CONTROL BY IONS AND OTHER CHEMICAL FACTORS
Many ions and other chemical factors can also affect vascular tone locally. Their effects are important in integrating circulatory responses at the tissue level.
Increased Calcium Ion Concentration → Vasoconstriction
Calcium ions are required for vascular smooth muscle contraction. An increase in calcium concentration in the extracellular fluid tends to cause vasoconstriction. This forms the basis for the use of calcium channel blockers (e.g., nifedipine, amlodipine, verapamil) as vasodilators and antihypertensive agents.
Increased Potassium Ion Concentration → Vasodilation
An increase in potassium concentration in the tissue fluid causes vasodilation. Because potassium is released from muscle cells during exercise, this provides an additional mechanism for active hyperemia in exercising muscle. Potassium causes vasodilation by hyperpolarizing or reducing the degree of depolarization of the smooth muscle cell membrane.
Increased Magnesium Ion Concentration → Vasodilation
Magnesium ions cause powerful vasodilation by inhibiting smooth muscle contraction. Intravenous magnesium sulfate is used clinically as a vasodilator, particularly in the management of eclampsia and severe hypertension.
Increased Hydrogen Ion (H⁺) Concentration (Decreased pH) → Vasodilation
Decreased pH (increased acidity) causes vasodilation. In active tissues, increased CO₂ and lactate production lowers local pH, contributing to local vasodilation and active hyperemia.
Increased CO₂ Concentration → Vasodilation
Carbon dioxide is one of the most potent vasodilators in the body, particularly in the cerebral circulation. In the brain, increases in arterial CO₂ (hypercapnia) cause marked cerebral vasodilation, increasing cerebral blood flow.
Increased Sodium Ion Concentration → Slight Vasodilation
A slight increase in sodium concentration causes osmotically-induced effects on the vessel wall.
Acetate and Citrate Ions
Both of these ions cause slight vasodilation, primarily by local mechanisms.
Anoxia → Vasodilation
Oxygen deficiency (anoxia) in tissues causes powerful vasodilation - this is a key component of the oxygen demand theory of local blood flow regulation.
Summary of Chapter 17 - Key Concepts
Figure 17.9 (summary diagram - schematic):
┌─────────────────────────────────────────────────────────────┐
│ LOCAL BLOOD FLOW CONTROL MECHANISMS │
├─────────────────────────┬───────────────────────────────────┤
│ ACUTE CONTROL │ LONG-TERM CONTROL │
│ (seconds-minutes) │ (days-weeks-months) │
├─────────────────────────┼───────────────────────────────────┤
│ Metabolic: │ Angiogenesis │
│ - ↑ metabolism → │ - VEGF, FGF, PDGF │
│ vasodilator release │ - New capillary formation │
│ (adenosine, CO₂, │ │
│ K⁺, H⁺, histamine) │ Rarefaction │
│ │ - Vessel dropout with │
│ Oxygen demand: │ reduced metabolic need │
│ - ↓ O₂ → smooth │ │
│ muscle relaxation │ Collateral development │
│ │ - Opens/enlarges bypass │
│ Myogenic: │ vessels │
│ - ↑ wall stretch → │ │
│ smooth muscle │ Vascular remodeling │
│ contraction │ - Diameter, wall thickness │
│ │ adapt to shear/pressure │
│ Endothelium-derived: │ │
│ - NO (vasodilator) │ │
│ - Endothelin │ │
│ (vasoconstrictor) │ │
├─────────────────────────┴───────────────────────────────────┤
│ HUMORAL CONTROL │
│ Vasoconstrictors: NE, Epi, Angiotensin II, ADH, Endothelin │
│ Vasodilators: Bradykinin, Histamine, Prostaglandins, NO │
│ Ions: Ca²⁺↑ → constrict; K⁺↑, Mg²⁺↑, H⁺↑, CO₂↑ → │
│ dilate │
└─────────────────────────────────────────────────────────────┘
Bibliography (Chapter 17)
Key references from Guyton Chapter 17 include works on:
- Local control of blood flow and microcirculation (Guyton AC, Ross JM, Carrier O Jr, Walker JR, 1964)
- Autoregulation of blood flow (Johnson PC)
- Reactive and active hyperemia mechanisms
- Nitric oxide biology (Furchgott RF, Zawadzki JV - Nobel Prize work)
- Vascular endothelial growth factor and angiogenesis
- Endothelin (Yanagisawa M et al., 1988)
- Renin-angiotensin system
- Vascular remodeling mechanisms
Source: Guyton and Hall Textbook of Medical Physiology, 14th Edition, Chapter 17 - "Local and Humoral Control of Tissue Blood Flow," pp. 211-221
---That is the complete Chapter 17: Local and Humoral Control of Tissue Blood Flow from Guyton and Hall, 14th Edition. Here is a quick orientation of everything covered:
Chapter 17 - Complete Coverage Summary
| Section | Key Content |
|---|
| Local Blood Flow Controlled by Tissue Needs | 6 metabolic needs; Table 17.1 (organ blood flows); importance of minimal-adequate flow |
| Mechanisms of Local Control | Acute (seconds-minutes) vs. Long-term (days-weeks) |
| Acute Control | Vasodilator theory (adenosine, CO₂, K⁺, H⁺, histamine); Oxygen demand theory |
| Reactive Hyperemia | 4-7× normal flow after occlusion release; repays oxygen debt |
| Active Hyperemia | Up to 20× flow during exercise; matches metabolic demand (Fig. 17.4 shown above) |
| Autoregulation | Metabolic + myogenic mechanisms; 70-175 mmHg range with only 20-30% flow change (Fig. 17.5) |
| Endothelium-Derived Factors | NO (vasodilator, shear-stress released, PDE-5 inhibitors); Endothelin (vasoconstrictor, 21-AA peptide, damage-released) |
| Long-Term Regulation | Angiogenesis (VEGF, FGF, PDGF), collateral development, vascular remodeling |
| Vascular Remodeling | A-V fistula example; shear → outward remodeling; pressure → hypertrophy |
| Humoral Vasoconstrictors | Norepinephrine, Epinephrine, Angiotensin II (1 µg raises BP 50 mmHg), Vasopressin |
| Humoral Vasodilators | Bradykinin (ACE degrades it - explains ACE inhibitor cough), Histamine, Prostaglandins |
| Ionic Control | Ca²⁺↑ = constrict; K⁺↑, Mg²⁺↑, H⁺↑, CO₂↑, anoxia = dilate |